The Author List Challenge | GenomeWeb

Disagreements over who goes where on an author list are common, but deciding ahead of time how credit will be doled out can limit those arguments, writes Amber Dance at Nature Jobs.

"The force of the dispute usually revolves around the feeling that whatever they did was more important than what the other person did," Stanford University's Stephen Kosslyn tells her.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.